Spots Global Cancer Trial Database for tecogalan
Every month we try and update this database with for tecogalan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | NCT00002136 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 | NCT00002137 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 | NCT00002137 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | NCT00002138 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Study of Tecogalan Sodium | NCT00002342 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | NCT00002138 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | NCT00002136 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | NCT00002138 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service | |
A Study of Tecogalan Sodium | NCT00002342 | Sarcoma, Kaposi HIV Infections | Tecogalan sodiu... | 18 Years - | NIH AIDS Clinical Trials Information Service |